142 research outputs found

    Highly Pathogenic Avian Influenza Virus H5N1 Infection in a Long-Distance Migrant Shorebird under Migratory and Non-Migratory States

    Get PDF
    Corticosterone regulates physiological changes preparing wild birds for migration. It also modulates the immune system and may lead to increased susceptibility to infection, with implications for the spread of pathogens, including highly pathogenic avian influenza virus (HPAIV) H5N1. The red knot (Calidris canutus islandica) displays migratory changes in captivity and was used as a model to assess the effect of high plasma concentration of corticosterone on HPAIV H5N1 infection. We inoculated knots during pre-migration (N = 6), fueling (N = 5), migration (N = 9) and post-migration periods (N = 6). Knots from all groups shed similar viral titers for up to 5 days post-inoculation (dpi), peaking at 1 to 3 dpi. Lesions of acute encephalitis, associated with virus replication in neurons, were seen in 1 to 2 knots per group, leading to neurological disease and death at 5 to 11 dpi. Therefore, the risk of HPAIV H5N1 infection in wild birds and of potential transmission between wild birds and poultry may be similar at different times of the year, irrespective of wild birds' migratory status. However, in knots inoculated during the migration period, viral shedding levels positively correlated with pre-inoculation plasma concentration of corticosterone. Of these, knots that did not become productively infected had lower plasma concentration of corticosterone. Conversely, elevated plasma concentration of corticosterone did not result in an increased probability to develop clinical disease. These results suggest that birds with elevated plasma concentration of corticosterone at the time of migration (ready to migrate) may be more susceptible to acquisition of infection and shed higher viral titers—before the onset of clinical disease—than birds with low concentration of corticosterone (not ready for take-off). Yet, they may not be more prone to the development of clinical disease. Therefore, assuming no effect of sub-clinical infection on the likelihood of migratory take-off, this may favor the spread of HPAIV H5N1 by migratory birds over long distances

    An in vitro model of early anteroposterior organization during human development.

    Get PDF
    The body plan of the mammalian embryo is shaped through the process of gastrulation, an early developmental event that transforms an isotropic group of cells into an ensemble of tissues that is ordered with reference to three orthogonal axes1. Although model organisms have provided much insight into this process, we know very little about gastrulation in humans, owing to the difficulty of obtaining embryos at such early stages of development and the ethical and technical restrictions that limit the feasibility of observing gastrulation ex vivo2. Here we show that human embryonic stem cells can be used to generate gastruloids-three-dimensional multicellular aggregates that differentiate to form derivatives of the three germ layers organized spatiotemporally, without additional extra-embryonic tissues. Human gastruloids undergo elongation along an anteroposterior axis, and we use spatial transcriptomics to show that they exhibit patterned gene expression. This includes a signature of somitogenesis that suggests that 72-h human gastruloids show some features of Carnegie-stage-9 embryos3. Our study represents an experimentally tractable model system to reveal and examine human-specific regulatory processes that occur during axial organization in early development

    Proteome changes in platelets activated by arachidonic acid, collagen, and thrombin

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Platelets are small anucleated blood particles that play a key role in the control of bleeding. Platelets need to be activated to perform their functions and participate in hemostasis. The process of activation is accompanied by vast protein reorganization and posttranslational modifications. The goal of this study was to identify changes in proteins in platelets activated by different agonists. Platelets were activated by three different agonists - arachidonic acid, collagen, and thrombin. 2D SDS-PAGE (pI 4-7) was used to separate platelet proteins. Proteomes of activated and resting platelets were compared with each other by Progenesis SameSpots statistical software; and proteins were identified by nanoLC-MS/MS.</p> <p>Results</p> <p>190 spots were found to be significantly different. Of these, 180 spots were successfully identified and correspond to 144 different proteins. Five proteins were found that had not previously been identified in platelets: protein CDV3 homolog, protein ETHE1, protein LZIC, FGFR1 oncogene partner 2, and guanine nucleotide-binding protein subunit beta-5. Using spot expression profile analysis, we found two proteins (WD repeat-containing protein 1 and mitochondrial glycerol-3-phosphate dehydrogenase) that may be part of thrombin specific activation or signal transduction pathway(s).</p> <p>Conclusions</p> <p>Our results, characterizing the differences within proteins in both activated (by various agonists) and resting platelets, can thus contribute to the basic knowledge of platelets and to the understanding of the function and development of new antiplatelet drugs.</p

    Direct Visualization by Cryo-EM of the Mycobacterial Capsular Layer: A Labile Structure Containing ESX-1-Secreted Proteins

    Get PDF
    The cell envelope of mycobacteria, a group of Gram positive bacteria, is composed of a plasma membrane and a Gram-negative-like outer membrane containing mycolic acids. In addition, the surface of the mycobacteria is coated with an ill-characterized layer of extractable, non-covalently linked glycans, lipids and proteins, collectively known as the capsule, whose occurrence is a matter of debate. By using plunge freezing cryo-electron microscopy technique, we were able to show that pathogenic mycobacteria produce a thick capsule, only present when the cells were grown under unperturbed conditions and easily removed by mild detergents. This detergent-labile capsule layer contains arabinomannan, α-glucan and oligomannosyl-capped glycolipids. Further immunogenic and proteomic analyses revealed that Mycobacterium marinum capsule contains high amounts of proteins that are secreted via the ESX-1 pathway. Finally, cell infection experiments demonstrated the importance of the capsule for binding to cells and dampening of pro-inflammatory cytokine response. Together, these results show a direct visualization of the mycobacterial capsular layer as a labile structure that contains ESX-1-secreted proteins

    Removal of the endocrine disrupter butyl benzyl phthalate from the environment

    Get PDF
    Butyl benzyl phthalate (BBP), an aryl alkyl ester of 1,2-benzene dicarboxylic acid, is extensively used in vinyl tiles and as a plasticizer in PVC in many commonly used products. BBP, which readily leaches from these products, is one of the most important environmental contaminants, and the increased awareness of its adverse effects on human health has led to a dramatic increase in research aimed at removing BBP from the environment via bioremediation. This review highlights recent progress in the degradation of BBP by pure and mixed bacterial cultures, fungi, and in sludge, sediment, and wastewater. Sonochemical degradation, a unique abiotic remediation technique, and photocatalytic degradation are also discussed. The degradation pathways for BBP are described, and future research directions are considered

    Present state and future perspectives of using pluripotent stem cells in toxicology research

    Get PDF
    The use of novel drugs and chemicals requires reliable data on their potential toxic effects on humans. Current test systems are mainly based on animals or in vitro–cultured animal-derived cells and do not or not sufficiently mirror the situation in humans. Therefore, in vitro models based on human pluripotent stem cells (hPSCs) have become an attractive alternative. The article summarizes the characteristics of pluripotent stem cells, including embryonic carcinoma and embryonic germ cells, and discusses the potential of pluripotent stem cells for safety pharmacology and toxicology. Special attention is directed to the potential application of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) for the assessment of developmental toxicology as well as cardio- and hepatotoxicology. With respect to embryotoxicology, recent achievements of the embryonic stem cell test (EST) are described and current limitations as well as prospects of embryotoxicity studies using pluripotent stem cells are discussed. Furthermore, recent efforts to establish hPSC-based cell models for testing cardio- and hepatotoxicity are presented. In this context, methods for differentiation and selection of cardiac and hepatic cells from hPSCs are summarized, requirements and implications with respect to the use of these cells in safety pharmacology and toxicology are presented, and future challenges and perspectives of using hPSCs are discussed

    Hormoonontregeling en volksgezondheid: Rapportage van een workshop

    No full text
    Within the project on endocrine disruption and human health one aim is to keep track with the state of the art as regards endocrine disrupter research relating to human health effects. This report summarizes the presentations given at the Workshop on the subject held in May 2000 in Copenhagen, which was organised by professor Niels Skakkebaek. The workshop brought together a considerable group of key scientists in the field. Both timely overviews as well as current research results were presented. The workshop concluded that endocrine disruption remains a matter of concern, although causal relationships between exposure to environmental endocrine disrupters and human health effects have not been proven to date. Particularly, human exposure data are needed to found a solid basis for actual human risk assessment in the field of endocrine disruption.In het kader van het project 'endocriene verstoring humaan' worden onder meer actuele ontwikkelingen gerapporteerd over de relatie tussen endocriene verstoring en humane effecten. Dit rapport geeft een overzicht van de presentaties die over dit onderwerp gegeven werden tijdens een workshop, gehouden in mei 2000 in Kopenhagen, die werd georganiserd door prof. Niels Skakkebaek. De workshop bracht een niet onaanzienlijke groep expert wetenschappers op dit terrein bijeen. Zowel actuele overzichtsverhalen als nieuwe resultaten van lopende researchprojecten werden gepresenteerd. De workshop concludeerde dat endocriene verstoring een onderwerp van zorg blijft, hoewel causale relaties tussen blootstelling aan endocriene stoffen via het milieu en gezondheidseffecten bij de mens tot op heden niet zijn aangetoond. Er zijn met name meer humane blootstellingsgegevens nodig als basis voor een actuele risicoschatting voor de mens met betrekking tot endocriene verstoring

    Hormoonontregeling en volksgezondheid: Rapportage van een workshop

    No full text
    In het kader van het project 'endocriene verstoring humaan' worden onder meer actuele ontwikkelingen gerapporteerd over de relatie tussen endocriene verstoring en humane effecten. Dit rapport geeft een overzicht van de presentaties die over dit onderwerp gegeven werden tijdens een workshop, gehouden in mei 2000 in Kopenhagen, die werd georganiserd door prof. Niels Skakkebaek. De workshop bracht een niet onaanzienlijke groep expert wetenschappers op dit terrein bijeen. Zowel actuele overzichtsverhalen als nieuwe resultaten van lopende researchprojecten werden gepresenteerd. De workshop concludeerde dat endocriene verstoring een onderwerp van zorg blijft, hoewel causale relaties tussen blootstelling aan endocriene stoffen via het milieu en gezondheidseffecten bij de mens tot op heden niet zijn aangetoond. Er zijn met name meer humane blootstellingsgegevens nodig als basis voor een actuele risicoschatting voor de mens met betrekking tot endocriene verstoring.Within the project on endocrine disruption and human health one aim is to keep track with the state of the art as regards endocrine disrupter research relating to human health effects. This report summarizes the presentations given at the Workshop on the subject held in May 2000 in Copenhagen, which was organised by professor Niels Skakkebaek. The workshop brought together a considerable group of key scientists in the field. Both timely overviews as well as current research results were presented. The workshop concluded that endocrine disruption remains a matter of concern, although causal relationships between exposure to environmental endocrine disrupters and human health effects have not been proven to date. Particularly, human exposure data are needed to found a solid basis for actual human risk assessment in the field of endocrine disruption.VWS Gezondheidsbelei
    corecore